Biopharmaceutical developers should introduce risk-based, phase-appropriate characterization strategies for quality control ...
Semiconductors are central to modern technology. They are used in computer chips, solar cells, sensors, LEDs and ...
Upcoming Type B Statistical Methods Meeting expected to set stage for FDA to align with EMA and MHRA on use of Fall 2026 ...
Immuron Engages Pullan Consulting to Advance IMM-529 Partnering Strategy; Immuron is seeking a partner to support clinical development through regulatory approval and ...
A breakthrough quantum sensor has shown it can uncover hidden signals through overwhelming noise, paving the way for future ...
Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced results from two Phase 1/2 ...
InflaRx intends to engage with EMA regarding both vilobelimab and izicopan to evaluate the regulatory path to approval in ANCA-associated vasculitis (AAV)The Company is assessing the most efficient ...
Rafael Holdings is a small, high-risk biotech company that is at the most vital juncture of its corporate history. See why I ...
Mount Etna’s past eruptions reveal that a single volcano can erupt through very different underground pathways.
A study published in Nature Physics provides new molecular-level evidence from simulations that liquid water is not a single uniform substance, but a constantly shifting mixture of two distinct ...
Explore the evolving landscape of male contraception, including novel nonhormonal pills and injectable hydrogels in clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results